EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine doses

Diego Carretero, Estela Giménez, Ariadna Pérez, Rafael Hernani, José Luis Piñana, Carlos Solano, David Navarro, Eliseo Albert

Enfermedades infecciosas y microbiologia clinica (English ed.) · 2026-05 · 44 (5) · 503146

DOI: 10.1016/j.eimce.2026.503146 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2026-05. Verfasst von Diego Carretero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Hauptthemen laut MEDLINE: Antibodies, Viral, Spike Glycoprotein, Coronavirus, COVID-19 Vaccines, SARS-CoV-2. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Studies assessing SARS-CoV-2 antibodies and functional T-cell responses in hematological patients following receipt of a three-dose mRNA vaccine schedule have yielded conflicting results. METHODS: T cells by flow cytometry and anti-receptor-binding domain (RBD) total antibodies in 32 hematological patients, including 10 allogeneic hematopoietic stem cell transplant (allo-HCT) recipients and 22 non-transplanted individuals. Immunological testing was performed after the second COVID-19 mRNA vaccine dose (Post-2D), prior to the third dose (Pre-3D), and after the third dose (Post-3D). RESULTS: T-cell responses and their frequencies were rather conserved at all testing times. Receiving a 3D had no significant impact on the rate of detection and frequencies of monofunctional and bifunctional SARS-CoV-2-S-directed T-cell subsets. Anti-RBD total antibody responses were detected in approximately half of participants at all time points. Overall, anti-RBD antibody levels decreased at Pre-3D and then increased following the 3D. CONCLUSION: Administration of the 3D may have a limited impact on both cellular and humoral immune responses in a substantial proportion of hematological patients. These findings highlight the heterogeneity of vaccine-induced immunity and support the role of combined immune monitoring and alternative protective strategies for selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralSpike Glycoprotein, CoronavirusCOVID-19 VaccinesSARS-CoV-2CD8-Positive T-LymphocytesCOVID-19Hematologic NeoplasmsT-LymphocytesHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedCD4-Positive T-LymphocytesCytokines

Stichwörter der Autor:innen

Anti-RBD antibodiesAnticuerpos anti-RBDBoosterCOVID-19 vaccineDosis de refuerzoInmunidad TSARS-CoV-2T-cell immunityVacuna COVID-19

Substanzen

Antibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 VaccinesCytokines

Autor:innen und Institutionen

  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Hematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Hematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Department of Microbiology School of…
  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Electronic address: Eliseo.al.vi@gmail.com.

Zitieren

APA

Carretero, D., Giménez, E., Pérez, A., Hernani, R., Piñana, J. L., Solano, C., Navarro, D., & Albert, E. (2026). SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine doses. Enfermedades infecciosas y microbiologia clinica (English ed.), 44(5), 503146. https://doi.org/10.1016/j.eimce.2026.503146

Vancouver

Carretero D, Giménez E, Pérez A, Hernani R, Piñana JL, Solano C, et al. SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine doses. Enfermedades infecciosas y microbiologia clinica (English ed.). 2026;44(5):503146. doi:10.1016/j.eimce.2026.503146

BibTeX
@article{Carretero2026,
  author = {Carretero, Diego and Giménez, Estela and Pérez, Ariadna and Hernani, Rafael and Piñana, José Luis and Solano, Carlos and Navarro, David and Albert, Eliseo},
  title = {SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine doses},
  journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
  year = {2026},
  volume = {44},
  number = {5},
  pages = {503146},
  doi = {10.1016/j.eimce.2026.503146}
}
Kostenlos starten →